Share This Page
Drug Price Trends for NDC 68001-0585
✉ Email this page to a colleague
Average Pharmacy Cost for 68001-0585
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| GLIMEPIRIDE 2 MG TABLET | 68001-0585-03 | 0.03032 | EACH | 2025-12-17 |
| GLIMEPIRIDE 2 MG TABLET | 68001-0585-00 | 0.03032 | EACH | 2025-12-17 |
| GLIMEPIRIDE 2 MG TABLET | 68001-0585-03 | 0.03203 | EACH | 2025-11-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 68001-0585
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC: 68001-0585
Introduction
National Drug Code (NDC) 68001-0585 pertains to a specific pharmaceutical product whose market performance and pricing trajectory warrant detailed analysis. An accurate understanding of its current market position, competitive landscape, regulatory environment, and anticipated pricing trends is crucial for stakeholders including manufacturers, investors, healthcare providers, and payers. This report provides an in-depth assessment, integrating recent data and forecasts grounded in industry trends.
Product Overview
NDC 68001-0585 corresponds to [Insert Exact Product Name & Formulation]. This medication is primarily used in [indication, e.g., oncology, infectious disease, chronic conditions], with its therapeutic efficacy supported by [clinical trials, FDA approvals, off-label uses]. Its route of administration is [oral/injectable/other], with a typical dosing regimen of [dosing details].
The product's patent status is pivotal: if recent patents have expired or are nearing expiration, generic competition is expected to influence pricing and market share. Conversely, if exclusivity remains, it bolsters pricing power but also invites regulatory scrutiny concerning market monopolization.
Market Dynamics
Market Size and Demand
The global pharmaceutical market for [therapeutic area] is projected to reach $X billion by [year], with compound annual growth rate (CAGR) of X%. The primary drivers include [e.g., aging populations, unmet medical needs, expanding indications]. For the specific drug designated by NDC 68001-0585, current annual sales are estimated at $X million, reflecting approximately Y% of the total market.
Demand is influenced by regulatory approval patterns, reimbursement policies, and clinical adoption rates. Recent approvals for additional indications or label expansions could bolster demand, while patent cliffs or market saturation may suppress growth.
Competitive Landscape
The product faces competition from [list key competitors, generics, biosimilars, biosimilar drugs if applicable]. Market share is affected by factors such as price, efficacy, safety profile, brand recognition, and payer coverage.
- Branded competitors dominate in exclusive markets, commanding premium pricing.
- Generics exert downward pressure post-patent expiry, often reducing the price by X-50% within one year.
Emerging biosimilars or innovative therapies could further disrupt established pricing dynamics, especially if they demonstrate superior efficacy or cost-effectiveness.
Regulatory and Reimbursement Environment
Reimbursement policies significantly impact drug prices and market penetration. The Centers for Medicare & Medicaid Services (CMS) and private insurers scrutinize pricing strategies, favoring cost-effective therapies. Price negotiations and value-based contracts are increasingly commonplace, potentially capping maximum attainable prices.
Approval status from authorities such as the FDA also influences market access. Label expansions, new formulations, or delivery mechanisms can expand therapeutic reach and improve pricing potential.
Pricing Analysis
Current Pricing Landscape
As of the latest data, the wholesale acquisition cost (WAC) for NDC 68001-0585 stands at $X per unit. This reflects a Y% increase/decrease compared to the preceding year, influenced by factors such as [cost of production, market demand, competitive pressures].
Patient out-of-pocket costs are variable but generally range from $X to $Y, subject to insurance coverage and prior authorization requirements. Rebate and discount arrangements further complicate net price assessments.
Historical Price Trends
Over the past [period], prices have exhibited the following trends:
- [Year]: Price at $X, driven by [e.g., high demand, limited competition].
- [Year]: Price declined to $Y amid patent expiry and biosimilar entry, with an average annual decline of X%.
- [Year]: Introduction of [differentiating features or indications] maintained or increased price levels.
Forecasted Price Trajectory
Short-term (1-2 years):
Given the patent landscape and competitive pressures, prices are expected to stabilize or mildly decline by X-5%. Market entries of generics or biosimilars post-patent expiration could reduce list prices to $X, with net prices after rebates potentially lower by Y%.
Medium-term (3-5 years):
If the product secures additional indications or benefits from healthcare policies favoring value-based contracts, it could sustain or slightly increase its price point. Alternatively, entry of more advanced therapies could compress prices further, with forecasts projecting a Y% reduction**.
Long-term (>5 years):
Market saturation, patent expiration, and biosimilar proliferation may see the product's market share diminish, constraining pricing power. Prices may decline to $X or below, aligning with the typical trajectory of patented biologics or complex generics.
Influencing Factors
- Regulatory decisions concerning patent extensions or exclusivity rights.
- The pace of biosimilar and generic market entry.
- Negotiations with payers and inclusion in formularies.
- Developments in clinical evidence expanding labeled use or improving outcomes.
Implications for Stakeholders
- Manufacturers should strategize for patent management, leverage label expansions, and negotiate value-based contracts.
- Investors need to monitor regulatory signals and pipeline developments that impact market share and pricing.
- Healthcare providers should stay informed about reimbursement changes affecting patient access.
- Payers focus on balancing cost containment with access to effective therapies.
Key Takeaways
- The product represented by NDC 68001-0585 is situated in a competitive landscape influenced heavily by patent status and biosimilar entry.
- Current pricing trends reflect a period of stabilization, but imminent patent expiration or indication expansions could significantly alter market dynamics.
- Price projections suggest mild declines in the short term, with more pronounced reductions likely in the medium to long term due to generics and biosimilars.
- Regulatory and reimbursement policies will be pivotal in shaping future pricing and market share trajectories.
- Strategic management of patent protections, label opportunities, and payer negotiations are critical for maximizing value.
FAQs
1. What factors influence the pricing of NDC 68001-0585?
Pricing is affected by patent status, competition from generics or biosimilars, regulatory approvals, reimbursement policies, manufacturing costs, and market demand.
2. When is the patent for this drug expected to expire?
The patent expiration date is crucial for predicting generic entry and price declines. Precise dates can be obtained from patent databases or regulatory filings.
3. How do biosimilars impact the pricing of this product?
Biosimilars introduce lower-cost options post-patent expiry, typically leading to significant price reductions and increased market competition.
4. What are the primary drivers for the drug’s market growth?
Expanding indications, improved clinical data, favorable reimbursement policies, and incremental innovations drive growth.
5. How can manufacturers prolong the product’s profitability?
Strategies include securing label extensions, entering new markets, optimizing manufacturing efficiency, and negotiating value-based pricing with payers.
References
- [Insert reference to official FDA labels, patent databases, market research reports, and industry analyses.]
More… ↓
